Finance

Lists
002793:SHE
Luoxin Pharmaceuticals Group Stock CoLtd
4,55 CN¥
-1,09%
(-0,050) 1D
16 қаз., 15:04:21 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002793...
Open
4,63 CN¥
High
4,80 CN¥
Low
4,49 CN¥
Mkt. cap
4,95 млрд
Avg. vol.
26,11 млн
Volume
30,24 млн
52-wk high
5,84 CN¥
52-wk low
3,70 CN¥
EPS
-0,24 CN¥
Shares outstanding
1,09 млрд
No. of employees
3 мың
Open
4,63 CN¥
High
4,80 CN¥
Low
4,49 CN¥
Mkt. cap
4,95 млрд
Avg. vol.
26,11 млн
Volume
30,24 млн
52-wk high
5,84 CN¥
52-wk low
3,70 CN¥
EPS
-0,24 CN¥
Shares outstanding
1,09 млрд
No. of employees
3 мың
News stories
From web sources and news partners
About Luoxin Pharmaceuticals Group Stock CoLtd
CEO-
Employees2,96 мың
Founded1998 ж. 11 мам.
Headquarters-
SectorPharmaceutical industry
Websiteluoxin.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
646,17 млн
550,04 млн
582,73 млн
564,73 млн
Cost of goods sold
284,62 млн
350,41 млн
227,21 млн
233,14 млн
Cost of revenue
284,62 млн
350,41 млн
227,21 млн
233,14 млн
Research and development expenses
25,45 млн
28,30 млн
18,23 млн
13,81 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
294,54 млн
416,72 млн
293,64 млн
255,71 млн
Operating expense
309,59 млн
473,08 млн
309,55 млн
276,59 млн
Total operating expenses
594,21 млн
823,49 млн
536,76 млн
509,72 млн
Operating income
51,96 млн
-273,45 млн
45,97 млн
55,00 млн
Other non operating income
-6,70 млн
5,56 млн
-892,17 м.
793,30 м.
EBT including unusual items
13,28 млн
-342,19 млн
42,70 млн
30,79 млн
EBT excluding unusual items
31,00 млн
-279,55 млн
48,11 млн
43,36 млн
Income tax expense
1,71 млн
-24,11 млн
13,70 млн
6,56 млн
Effective tax rate
12,91%
7,04%
32,09%
21,29%
Other operating expenses
-11,73 млн
23,50 млн
3,46 млн
6,40 млн
Net income
5,23 млн
-311,51 млн
24,15 млн
25,78 млн
Net profit margin
0,81%
-56,63%
4,14%
4,57%
Earnings per share
-
-
-
-
Interest and investment income
-
1,02 млн
16,52 млн
-
Interest expense
-15,39 млн
-12,19 млн
-13,48 млн
-11,80 млн
Net interest expenses
-15,39 млн
-11,17 млн
3,04 млн
-11,80 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
99,78 млн
-224,55 млн
94,87 млн
97,95 млн
Gain or loss from assets sale
4,28 млн
-3,08 млн
-
-330,98 м.
AI content may include mistakes. Learn more
Google қолданбалары